Top compounds associated with response to ERVK3-1


Feature Type Standardized
Nominal ANOVA
mRNA importazole CTRPv2 pan-cancer AAC -0.089 0.02
mRNA tamatinib CTRPv2 pan-cancer AAC -0.085 0.03
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC 0.13 0.03
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.03
mRNA AGK-2 CTRPv2 pan-cancer AAC -0.083 0.03
mRNA CD-1530 CTRPv2 pan-cancer AAC -0.084 0.03
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC -0.17 0.03
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.03
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC -0.072 0.03
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.072 0.03
Download CSV